CLS A.I CyberSecurity Scoring
21/02/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Corning Life Sciences in 2026.
No incidents recorded for Corning Life Sciences in 2026.
No incidents recorded for Corning Life Sciences in 2026.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.
Latest updates, reports, and threat intel affecting the global network.
Corning Inc., a global leader in materials science, has released its 2025 Form 10-K report, showcasing a year of robust financial growth and...
The London Company, an investment management company, released “The London Company Income Equity Strategy” third-quarter 2025 investor...
The headline numbers for Corning (GLW) give insight into how the company performed in the quarter ended September 2025,...
Hyderabad: US giant Corning and French player SGD Pharma on Monday formally inaugurated their joint venture glass tubing manufacturing plant...
GLW's 43.6% YTD surge is fueled by solid traction in the optical communication and Specialty Materials segments, and major tech partnerships...
GLW tops Q2 estimates as Optical Communications revenues jump 41% and Gen AI demand boosts enterprise sales.
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a CEO succession plan under which John Duke will assume the role of President & CEO...
Eric S. Musser, president and chief operating officer, will retire later this year after 39 years of exceptional service across the company.
Corning Inc., a global leader in materials science, has released its 2024 Form 10-K report, detailing significant financial growth, strategic initiatives, and...
A vulnerability was identified in Totolink A3002MU Hh-B20211125.1046. Affected is the function formWlEncrypt of the file /boafrm/formWlEncrypt. The manipulation of the argument submit-url leads to buffer overflow. It is possible to initiate the attack remotely. The exploit is publicly available and might be used.
A vulnerability was determined in Totolink A3002MU Hh-B20211125.1046. This impacts the function formWlAc of the file /boafrm/formWlAc. Executing a manipulation of the argument submit-url can lead to buffer overflow. The attack may be performed from remote. The exploit has been publicly disclosed and may be utilized.
A flaw was found in the OpenShift console. Unauthenticated access to the `/api/devfile/` and `/api/devfile/samples/` endpoints allows a remote attacker to send crafted devfile payloads. This can lead to Server-Side Request Forgery (SSRF), where the console pod makes requests to internal services and reflects partial responses to the attacker. Additionally, by sending repeated large requests without a specified content length, an attacker can cause unbounded memory growth, leading to a Denial of Service (DoS).
In Vinyl Cache before 9.0,2, workspace buffer overflow vulnerability was found in the .upper() and .lower() string type methods of VCL. This can be used as a remote denial of service (DoS) vector to make the child process segfault or assert, and then restart. Effectively exploiting this vulnerability requires prior knowledge about the VCL in use and the ability to craft a request that contains a string that is long enough to fill the remaining workspace at the call site while staying under the different request size limits (http_req_size, http_req_hdr_len, etc.).
A vulnerability was found in Totolink A3002MU Hh-B20211125.1046. This affects the function formSchedule of the file /boafrm/formSchedule. Performing a manipulation of the argument webpage results in buffer overflow. The attack is possible to be carried out remotely. The exploit has been made public and could be used.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.